Page last updated: 2024-11-05

ici 204,219 and Adenocarcinoma of Lung

ici 204,219 has been researched along with Adenocarcinoma of Lung in 1 studies

zafirlukast: a leukotriene D4 receptor antagonist

Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.

Research Excerpts

ExcerptRelevanceReference
"Lung cancer has the highest mortality among cancers worldwide due to its high incidence and lack of the effective cures."1.72Zafirlukast inhibits the growth of lung adenocarcinoma via inhibiting TMEM16A channel activity. ( An, H; Li, G; Liu, W; Ma, B; Qu, C; Shi, D; Shi, S; Sun, F; Zhang, H, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Shi, S1
Ma, B1
Sun, F1
Qu, C1
Li, G1
Shi, D1
Liu, W1
Zhang, H1
An, H1

Other Studies

1 other study available for ici 204,219 and Adenocarcinoma of Lung

ArticleYear
Zafirlukast inhibits the growth of lung adenocarcinoma via inhibiting TMEM16A channel activity.
    The Journal of biological chemistry, 2022, Volume: 298, Issue:3

    Topics: Adenocarcinoma of Lung; Animals; Anoctamin-1; Chloride Channels; Indoles; Lung Neoplasms; Mice; Phen

2022